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Statement of findings
Current smoking was strongly and inversely associated with high-risk patterns, after
adjustment for concomitant risk factors. Relative to never smokers, current smokers were
significantly less likely to have a high-risk pattern. Similar results were obtained when the
analysis was confined to postmenopausal women. Past smoking was not related to the
mammographic parenchymal patterns. The overall effect in postmenopausal women lost its
significance when adjusted for other risk factors for P2/DY patterns that were found to be
significant in the present study, although the results are still strongly suggestive. The present
data indicate that adjustment for current smoking status is important when evaluating the
relationship between mammographic parenchymal pattern and breast cancer risk. They also
indicate that smoking is a prominent potential confounder when analyzing effects of other risk
factors such as obesity-related variables. It appears that parenchymal patterns may act as an
informative biomarker of the effect of cigarette smoking on breast cancer risk.
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CI = confidence interval; EPIC = European Prospective Investigation on Cancer; OR = odds ratio.
Introduction: Overall, epidemiological studies [1–4] have
reported no substantial association between cigarette smoking
and the risk of breast cancer. Some studies [5–7] reported a
significant increase of breast cancer risk among smokers. In
recent studies that addressed the association between breast
cancer and cigarette smoking, however, there was some
suggestion of a decreased risk [8–10], especially among current
smokers, ranging from approximately 10 to 30% [9,10]. Brunet
et al [11] reported that smoking might reduce the risk of breast
cancer by 44% in carriers of BRCA1 or BRCA2 gene mutations.
Wolfe [12] described four different mammographic patterns
created by variations in the relative amounts of fat, epithelial and
connective tissue in the breast, designated N1, P1, P2 and DY.
Women with either P2 or DY pattern are considered at greater
risk for breast cancer than those with N1 or P1 pattern [12–15].
There are no published studies that assessed the relationship
between smoking and mammographic parenchymal patterns.
Aims: To evaluate whether mammographic parenchymal
patterns as classified by Wolfe, which have been positively
associated with breast cancer risk, are affected by smoking. In
this case–control study, nested within the European
Prospective Investigation on Cancer in Norfolk (EPIC-Norfolk)
cohort [16], the association between smoking habits and
mammographic parenchymal patterns are examined. The full
results will be published elsewhere.
Methods: Study subjects were members of the EPIC cohort in
Norwich who also attended the prevalence screening round at
the Norwich Breast Screening Centre between November
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1989 and December 1997, and were free of breast cancer at
that screening. Cases were defined as women with a P2/DY
Wolfe’s mammographic parenchymal pattern on the prevalence
screen mammograms. A total of 203 women with P2/DY
patterns were identified as cases and were individually
matched by date of birth (within 1 year) and date of prevalence
screening (within 3 months) with 203 women with N1/P1
patterns who served as control individuals.
Two views, the mediolateral and craniocaudal mammograms, of
both breasts were independently reviewed by two of the
authors (ES and RW) to determine the Wolfe mammographic
parenchymal pattern.
Considerable information on health and lifestyle factors was
available from the EPIC Health and Lifestyle Questionnaire
[16]. In the present study we examined the subjects’ personal
history of benign breast diseases, menstrual and reproductive
factors, oral contraception and hormone replacement therapy,
smoking, and anthropometric information such as body mass
index and waist:hip ratio.
Odds ratios (ORs) and their 95% confidence intervals (CIs)
were calculated by conditional logistic regression [17], and
were adjusted for possible confounding factors.
Results: The characteristics of the cases and controls are
presented in Table 1. Cases were leaner than controls. A larger
percentage of cases were nulliparous, premenopausal, current
hormone replacement therapy users, had a personal history of
benign breast diseases, and had had a hysterectomy. A larger
proportion of controls had more than three births and were
current smokers.
Table 2 shows the unadjusted and adjusted OR estimates for
Wolfe’s high-risk mammographic parenchymal patterns and
smoking in the total study population and in postmenopausal
women separately. Current smoking was strongly and inversely
associated with high-risk patterns, after adjustment for
concomitant risk factors. Relative to never smokers, current
smokers were significantly less likely to have a high-risk pattern
(OR 0.37, 95% CI 0.14–0.94). Similar results were obtained
when the analysis was confined to postmenopausal women.
Past smoking was not related to mammographic parenchymal
patterns. The overall effect in postmenopausal women lost its
significance when adjusted for other risk factors for P2/DY
patterns that were found to be significant in the present study,
although the results were still strongly suggestive. There was no
interaction between cigarette smoking and body mass index.
Discussion: In the present study we found a strong inverse
relationship between current smoking and high-risk mammo-
graphic parenchymal patterns of breast tissue as classified by
Wolfe [12]. These findings are not completely unprecedented;
Greendale et al [18] found a reduced risk of breast density in
association with smoking, although the magnitude of the
reduction was unclear. The present findings suggest that this
reduction is large.
Recent studies [9,10] have suggested that breast cancer risk
may be reduced among current smokers. In a multicentre Italian
case–control study, Braga et al [10] found that, relative to
nonsmokers, current smokers had a reduced risk of breast
cancer (OR 0.84, 95% CI 0.7–1.0). These findings were
recently supported by Gammon et al [9], who reported that
breast cancer risk in younger women (younger than 45 years)
may be reduced among current smokers who began smoking
at an early age (OR 0.59, 95% CI 0.41–0.85 for age 15 years
or younger) and among long-term smokers (OR 0.70, 95% CI
0.52–0.94 for those who had smoked for 21 years or more).
The possible protective effect of smoking might be due to its anti-
oestrogenic effect [1,2,19]. Recently there has been renewed
interest in the potential effect of smoking on breast cancer risk,
and whether individuals may respond differently on the basis of
differences in metabolism of bioproducts of smoking [20,21].
Different relationships between smoking and breast cancer risk
have been suggested that are dependent on the rapid or slow
status of acetylators of aromatic amines [20,21]. More recent
studies [22,23], however, do not support these findings.
Table 1
Characteristics of the study population
Cases Controls
(P2+DY; (N1+P1;
Characteristics n = 203) n = 203)
Mean age (years) 59.3 59.3
Mean body mass index 25.2 27.4
Mean waist:hip ratio 2.1 2.4
Menopausal status (n)
Premenopausal 44 24
Postmenopausal 148 165
Unknown 11 14
Mean age at menarche (years) 13.0 12.7
Mean age at menopause (years) 47.7 47.0
Number of children (n)
03 1 1 6
12 7 2 6
29 6 8 2
33 4 4 7
4+ 15 29
Unknown – 3
History of benign breast diseases (n)
No 188 198
Yes 15 5
Hysterectomy (n)
No 141 152
Yes 60 49
Unknown 2 2
HRT use (n)
Never 106 131
Past 22 25
Current 73 43
Unknown 2 4
Smoking (n)
Never 121 120
Past 62 53
Current 20 30
HRT, hormone replacement therapy.61
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The present study design minimized the opportunity for bias to
influence the findings. Because subjects were unaware of their
own case–control status, the possibility of recall bias in
reporting smoking status was minimized. Systematic error in
the assessment of mammograms was avoided because
reading was done without knowledge of the risk factor data.
Furthermore, the associations observed are unlikely to be
explained by the confounding effect of other known breast
cancer risk factors, because we adjusted for these in the
analysis. We did not have information on passive smoking
status, however, which has recently been reported to be a
possible confounder [5,6,21,24].
The present data indicate that adjustment for current smoking
status is important when evaluating the relationship between
mammographic parenchymal pattern and breast cancer risk.
They also indicate smoking as a prominent potential
confounder when analyzing effects of other risk factors such as
obesity-related variables. It seems that parenchymal patterns
may act as an informative biomarker of the effect of cigarette
smoking on breast cancer risk.
Table 2
Odds ratio estimates for high-risk mammographic patterns according to smoking status
Cases Controls 
Smoking status (P2+DY) (N1+P1) OR 95% CI OR* 95% CI*
All women (n)
Never 121 120 1.00 – 1.00 –
Past 62 53 1.18 0.73–1.90 1.02 0.55–1.90
Current 20 30 0.65 0.34–1.24 0.37 0.14–0.94
Postmenopausal women (n)
Never 89 91 1.00 – 1.00 –
Past 45 46 0.99 0.54–1.82 1.27 0.60–2.67
Current 14 28 0.37 0.15–0.90 0.39 0.13–1.11
*Adjusted for menopausal status, parity, hormone replacement therapy, history of benign breast diseases, body mass index and waist:hip ratio in
the whole study population; adjusted for parity, hysterectomy, body mass index, and waist:hip ratio in postmenopausal women. OR, odds ratio;
CI, confidence interval.
Introduction
Overall, epidemiological studies [1–4] have reported no
substantial association between cigarette smoking and
the risk of breast cancer. Some studies [5–7] reported a
significant increase of breast cancer risk among smokers.
It has been suggested [5,6,21,24] that passive exposure
to cigarette smoking may alter prior associations seen
when only active smoking was assessed, with increased
risk being observed for passive smoking exposure. Fur-
thermore, there is a possibility of heterogeneity in the
response to the carcinogenic effect of smoking, which
might explain inconsistent findings for cigarette smoking
as a risk factor for breast cancer [20].
In recent studies that addressed the association between
breast cancer and cigarette smoking, however, there was
some suggestion of a decreased risk [8–10], especially
among current smokers, ranging from approximately 10 to
30% [9,10]. Brunet et al [11] reported that smoking might
reduce the risk of breast cancer by 44% in carriers of
BRCA1 or  BRCA2 gene mutations.
Wolfe [21] described four different mammographic pat-
terns that are created by variations in the relative amounts
of fat, epithelial and connective tissue in the breast, desig-
nated N1, P1, P2 and DY. Women with either P2 or DY
patterns are considered to be at greater risk for breast
cancer than those with N1 or P1 pattern [12–15].
There are no published studies that assessed the relationship
between smoking and mammographic parenchymal patterns.
The aim of the present study was to evaluate whether
mammographic parenchymal patterns as classified by
Wolfe [12], which have been positively associated with
breast cancer risk, are affected by smoking. In the present
case–control study, nested within the European Prospec-
tive Investigation on Cancer in Norfolk (EPIC-Norfolk)
cohort [16], the association between smoking habits and
mammographic parenchymal patterns are examined. The
full results will be published elsewhere.
Materials and methods
Study subjects were members of the EPIC cohort in
Norwich [16], who also attended the prevalence screen-
ing round at the Norwich Breast Screening Centre
between November 1989 and December 1997 and were
free of breast cancer at that screening. A case–control
study was designed within this cohort.
Cases were defined as women with a P2/DY Wolfe’s
mammographic parenchymal pattern on the prevalencescreen mammogram. Assuming a 2.5-fold increase in risk
of P2/DY mammographic patterns from the lowest quintile
of a quantitative factor to the highest, 200 cases and 200
controls will yield a power of approximately 90%. A total of
203 women with P2/DY patterns were identified as cases
and were individually matched by date of birth (within 1
year) and date of prevalence screening (within 3 months)
to 203 women with N1/P1 patterns who served as con-
trols. Additional information regarding case selection is
presented elsewhere [25].
We examined the screening records of each woman.
Mammograms of both breasts were collected. Two views,
the mediolateral and craniocaudal mammograms, of both
breasts were independently reviewed by two of the
authors (ES and RW) to determine the Wolfe mammo-
graphic parenchymal pattern. The inter-reader agreement
in the classification of mammographic parenchymal pat-
terns was 95% on the four pattern categories, and 99%
when the P2 and DY categories were combined, but for
the purposes of the present study we used only the films
in which we agreed on the patterns.
Considerable information on health and lifestyle factors
was available from the EPIC Health and Lifestyle Ques-
tionnaire [16]. In the present study we examined the sub-
jects’ personal and family history of benign breast
diseases and cancer, menstrual and reproductive factors,
oral contraception and hormone replacement therapy,
physical activity, smoking, and anthropometric information
such as body mass index and waist:hip ratio.
Statistical methods
Odds ratios (ORs) and their 95% confidence intervals
(CIs) were calculated by conditional logistic regression,
which takes into account the matching of controls to
cases [17]. Adjustment was performed for those variables
that were previously found to be associated with high-risk
mammographic parenchymal patterns [25].
Results
The characteristics of the cases and controls are presented in
Table1. The mean age of cases and controls was similar
(because they were matched on date of birth). Cases were
leaner than controls. A larger percentage of cases were nulli-
parous, similar proportions of cases and controls had between
one and three births, and a larger proportion of controls had
more than three births. A larger proportion of cases were pre-
menopausal, current hormone replacement therapy users, had
a personal history of benign breast diseases, and had had a
hysterectomy, whereas a larger proportion of controls were
current smokers. The cases and controls were similar with
respect to age at menarche and age at menopause.
Table 2 shows the unadjusted and adjusted OR estimates
for Wolfe’s high-risk mammographic parenchymal patterns
and smoking in the total study population and in post-
menopausal women separately. Current smoking was
strongly and inversely associated with high-risk patterns,
after adjustment for concomitant risk factors. Relative to
never smokers, current smokers were significantly less
likely to have a high-risk pattern (OR 0.37, 95% CI
0.14–0.94). Similar results were obtained when the analy-
sis was confined to postmenopausal women. Past smoking
was not related to the mammographic parenchymal pat-
terns. The overall effect in postmenopausal women lost its
statistical significance when adjusted for other risk factors
for P2/DY patterns that were found to be significant in this
study, although the results are still strongly suggestive.
There was no interaction between cigarette smoking and
body mass index (P=0.73 and 0.72 in the whole study
population and in postmenopausal women, respectively).
Discussion
In the present study, we found a strong inverse relation-
ship between current smoking and mammographic
parenchymal patterns of breast tissue as classified by
Wolfe [12]. These findings are not completely unprece-
dented; Greendale et al [18] found a reduced risk of
breast density in association with smoking, although the
magnitude of the reduction was unclear. Our findings
suggest that this reduction is large.
Recent studies [9,10] suggest that breast cancer risk may
be reduced among current smokers. In a multicentre
Italian case–control study, Braga et al [10] found that, rel-
ative to nonsmokers, current smokers had a reduced risk
of breast cancer (OR 0.84, 95% CI 0.7–1.0). These find-
ings were recently supported by Gammon et al [9], who
reported that breast cancer risk in younger women
(younger than 45 years) may be reduced among current
smokers who began smoking at an early age (OR 0.59,
95% CI 0.41–0.85 for age 15 years or younger) and
among long-term smokers (OR 0.70, 95% CI 0.52–0.94
for those who had smoked for 21 years or longer).
The possible protective effect might be due to the anti-
oestrogenic effect of smoking [1,2,19]. Exposure to ciga-
rette smoking causes an earlier menopause [1,26].
Smoking appears to alter the metabolism of oestradiol
leading to enhanced formation of the inactive catechol
estrogens [1]. Furthermore, smoking increases circulating
androgens through adrenal cortical stimulation [2], but the
conversion rates of androgens to oestrogens are lower in
those who smoke [27]. There has been a recent resur-
gence of interest in the potential effect of smoking on
breast cancer risk, and whether individuals may respond
differently on the basis of differences in metabolism of bio-
products of smoking [20,21]. Different relationships
between smoking and breast cancer risk have been sug-
gested that are dependent on the rapid or slow status of
acetylators of aromatic amines [20,21], rapid acetylators
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tobacco compounds. More recent studies [22,23] do not
support these findings, however.
The present study design minimized the opportunity for bias
to influence the findings. Systematic error in the assessment
of mammograms was avoided because reading was done
without knowledge of the risk factor data. Because subjects
were unaware of their own case–control status, the possi-
bility of recall bias in reporting smoking status was mini-
mized. Furthermore, the associations observed are unlikely
to be explained by the confounding effect of other known
breast cancer risk factors, because we adjusted for these in
the analysis. We did not have information on passive
smoking status, however, which has recently been reported
as a possible confounder [5,6,21,24].
Although, ideally we would have liked to evaluate the rela-
tionship between intensity and duration of smoking and
mammographic parenchymal patterns among current
smokers, the numbers were too small to perform the analy-
sis. Trends for intensity and duration of smoking were not
monotonic, and P values were inconclusive (between 0.05
and 0.1). Age at menopause and time since menopause
were not related to mammographic patterns in the present
study (data not shown). Although current smokers were
likely to have an early menopause (70% of current smokers
were postmenopausal before age 50 years), there was no
difference among mean age at menopause in the three
smoking categories (P=0.15). There was no difference in
time since menopause among current smokers.
These data indicate that adjustment for current smoking
status is important when evaluating the relationship
between mammographic parenchymal patterns and breast
cancer risk. They also indicate smoking to be a prominent
potential confounder when analyzing effects of other risk
factors, such as obesity-related variables. It appears that
parenchymal patterns may act as an informative biomarker
of the effect of cigarette smoking on breast cancer risk.
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